PRESS RELEASE published on 01/07/2026 at 22:05, 8 months 14 days ago Abivax présente ses perspectives pour 2026 Abivax présente ses perspectives pour 2026, annonçant des nouveautés dans le traitement de la rectocolite hémorragique, les progrès des essais ABTECT-UC et ENHANCE-CD, et l'avancement de son portefeuille de candidats médicaments Abivax Maladies Inflammatoires Chroniques Rectocolite Hémorragique Essais Cliniques Perspectives 2026
PRESS RELEASE published on 01/07/2026 at 22:05, 8 months 14 days ago Abivax Provides 2026 Corporate Outlook Abivax provides 2026 corporate outlook, highlighting market insights, trial progress, and pipeline advancements in treating chronic inflammatory diseases like UC and CD Abivax Chronic Inflammatory Diseases 2026 Corporate Outlook UC CD
BRIEF published on 12/18/2025 at 22:10, 9 months 3 days ago Abivax joins the Nasdaq Biotechnology index Biotechnology Abivax Obefazimod Ulcerative Colitis Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 9 months 3 days ago Abivax rejoint l'indice Nasdaq Biotechnology Biotechnologie Abivax Obefazimod Rectocolite Hémorragique Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 9 months 3 days ago Abivax Joins Nasdaq Biotechnology Index Biotechnology Abivax Obefazimod Ulcerative Colitis Nasdaq Biotechnology Index
BRIEF published on 12/18/2025 at 22:10, 9 months 3 days ago Abivax intègre l'indice Nasdaq Biotechnology Biotechnologie Abivax Obefazimod Rectocolite Hémorragique Indice Nasdaq Biotechnology
PRESS RELEASE published on 12/18/2025 at 22:05, 9 months 3 days ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology Abivax intègre l'Indice Biotechnologie du Nasdaq, témoignant de sa croissance et de ses avancées cliniques. Le NBI suit les performances des sociétés du secteur Biotechnologie Abivax Nasdaq Clinique NBI
PRESS RELEASE published on 12/18/2025 at 22:05, 9 months 3 days ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology Abivax intègre l'indice Nasdaq Biotechnology, rejoignant le NBI avec impact le 22 décembre 2025. Un pas significatif pour la société de biotechnologie française Biotechnologie Abivax France Nasdaq Biotechnology Indice
PRESS RELEASE published on 12/18/2025 at 22:05, 9 months 3 days ago Abivax to be Added to Nasdaq Biotechnology Index Abivax to be added to Nasdaq Biotechnology Index, reflecting company's progress in developing therapeutics for chronic inflammatory diseases. Inclusion effective December 22, 2025 Biotechnology Abivax Therapeutics Immune Response Nasdaq Biotechnology Index
BRIEF published on 12/17/2025 at 22:10, 9 months 4 days ago Abivax: 22 Abstracts on Obefazimod Presented at ECCO 2026 Abivax Obefazimod Efficiency Fibrosis IBD
Published on 09/22/2026 at 08:00, 48 minutes ago Coretura Selects Alloy Kore to Advance a Unique Software-Defined Vehicle Platform for Its Commercial Vehicle Customers
Published on 09/22/2026 at 08:00, 48 minutes ago Caledonia Mining Corporation PLC: Notification of Relevant Change to Significant Shareholder
Published on 09/22/2026 at 06:45, 2 hours 3 minutes ago Akkodis and Hamburg Public Transport Association Showcase hvv mia at InnoTrans 2026, Demonstrating the Future of AI-Powered Mobility
Published on 09/22/2026 at 06:45, 2 hours 3 minutes ago Akkodis et l’association des transports publics de Hambourg présentent hvv mia à InnoTrans 2026 et montrent comment l’IA transforme la mobilité.
Published on 09/22/2026 at 06:45, 2 hours 3 minutes ago Akkodis en Hamburger Verkehrsverbund presenteren hvv mia op InnoTrans 2026 en tonen de toekomst van AI-gedreven mobiliteit
Published on 09/22/2026 at 08:30, 18 minutes ago EQS-Adhoc: Katjes Greenfood resolves to issue a new corporate bond
Published on 09/22/2026 at 08:30, 18 minutes ago TAKKT AG: Stépan Breedveld to Take Over as Chairman of the Supervisory Board
Published on 09/22/2026 at 08:25, 23 minutes ago Breda University: how cycling infrastructure can unlock the future of urban mobility
Published on 09/22/2026 at 08:20, 27 minutes ago ExploRNA Therapeutics and Łukasiewicz - IChP Announce Strategic Partnership to Advance GMP Manufacturing of Next-Generation mRNA Cap Analogs
Published on 09/21/2026 at 18:19, 14 hours 29 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 14 hours 29 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 14 hours 46 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 15 hours 2 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 15 hours 2 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026
